Loading…
Loading…
research
Microbiotica is a clinical-stage biopharmaceutical company focused on developing precision live biotherapeutic products (LBPs) derived from the human microbiome. Founded in 2016 as a spin-out from the Wellcome Sanger Institute, the company is based in Cambridge, UK, and has successfully raised £62 million in equity investment, including a significant £50 million Series B funding round in 2022. The company utilizes a proprietary microbiome profiling platform that includes a diverse culture collection of bacterial strains, a reference genome database, and advanced bioinformatics tools. This platform supports a clinic-led discovery approach, allowing Microbiotica to identify specific bacterial strains linked to positive health outcomes. Their lead candidates include MB097, aimed at enhancing immune checkpoint inhibitors for melanoma, and MB310, targeting ulcerative colitis. Microbiotica is also exploring additional therapeutic candidates across various disease areas, including inflammatory bowel disease and immuno-oncology. The company has partnered with Genentech to analyze patient samples and develop new therapeutic products.
Microbiotica is a clinical-stage biopharmaceutical company focused on developing precision live biotherapeutic products (LBPs) derived from the human microbiome. Founded in 2016 as a spin-out from the Wellcome Sanger Institute, the company is based in Cambridge, UK, and has successfully raised £62 million in equity investment, including a significant £50 million Series B funding round in 2022. The company utilizes a proprietary microbiome profiling platform that includes a diverse culture collection of bacterial strains, a reference genome database, and advanced bioinformatics tools. This platform supports a clinic-led discovery approach, allowing Microbiotica to identify specific bacterial strains linked to positive health outcomes. Their lead candidates include MB097, aimed at enhancing immune checkpoint inhibitors for melanoma, and MB310, targeting ulcerative colitis. Microbiotica is also exploring additional therapeutic candidates across various disease areas, including inflammatory bowel disease and immuno-oncology. The company has partnered with Genentech to analyze patient samples and develop new therapeutic products.
Microbiotica has been mentioned across 2 podcasts.
Represent this company? Request removal or email privacy@pitchcentric.com.
FAQs
If you have a concern about deliverability, AI quality, data privacy, or whether this will actually work for your specific situation, it's probably answered below.
Founder Solo gives you 50 AI pitches per month using the credit model (Standard pitches cost 1 credit, Enriched pitches cost 2). Founder Pro raises that to 200 credits per month and adds full Booking Probability access, unlimited Magic Match, Apollo enrichment credits, and data export capabilities. Both plans use the same credit system, so you can stretch your monthly budget further by using Standard-mode drafting.
Agency tiers have no base fee. You pay per managed client and per talent profile. Agency Standard is $199 per client per month; Agency Pro is $399 per client per month. Both add $39 per talent profile per month. Your own team's user seats are always free.
A talent profile represents one person (founder, executive, or spokesperson) you are booking onto podcasts. It includes their bio, topics, headshots, and outreach history. Team plans include 5 profiles; agency plans are pay-as-you-go.
Yes, at any time. Upgrades take effect immediately; downgrades apply at the end of the current billing period. Contact support if you need help migrating between plan families.
Every paid plan includes a 15-day free trial. Your card is saved at signup but you will not be charged until day 16. Cancel any time from your dashboard.
You keep access until the end of your current billing period. No charges after that. Your data is retained for 30 days in case you reactivate.
Yes. Select Annual on the pricing toggle and the discounted price is applied automatically at checkout. The annual price shown is the full year cost.
That is our Enterprise tier. Contact our sales team and we will build a custom plan with volume pricing, a dedicated account manager, and SLA guarantees.
